Literature DB >> 12935891

Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.

Peter V Binevski1, Elena A Sizova, Vladimir F Pozdnev, Olga A Kost.   

Abstract

The somatic isoform of angiotensin-converting enzyme (ACE) consists of two homologous domains (N- and C-domains), each bearing a catalytic site. We have used the two-domain ACE form and its individual domains to compare characteristics of different domains and to probe mutual functioning of the two active sites within a bovine ACE molecule. The substrate Cbz-Phe-His-Leu (N-carbobenzoxy-L-phenylalanyl-L-histidyl-L-leucine; from the panel of seven) was hydrolyzed faster by the N-domain, the substrates FA-Phe-Gly-Gly (N-(3-[2-furyl]acryloyl)-L-phenylalanyl-glycyl-glycine) and Hip-His-Leu (N-benzoyl-glycyl-L-histidyl-L-leucine) were hydrolyzed by both domains with equal rates, while other substrates were preferentially hydrolyzed by the C-domain. The inhibitor captopril ((2S)-1-(3-mercapto-2-methylpropionyl)-L-proline) bound to the N-domain more effectively than to the C-domain, whereas lisinopril ((S)-N(alpha)-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline) bound to equal extent with all ACE forms. However, active site titration with lisinopril assayed by hydrolysis of FA-Phe-Gly-Gly revealed that 1 mol of inhibitor/mol of enzyme abolished the activity of either two-domain or single-domain ACE forms, indicating that a single active site functions in bovine somatic ACE. Neither of the k(cat) values obtained for somatic enzyme was the sum of k(cat) values for individual domains, but in every case the value of the catalytic constant of the hydrolysis of the substrate by the two-domain ACE represented the mean quantity of the values of the corresponding catalytic constants obtained for single-domain forms. The results indicate that the two active sites within bovine somatic ACE exhibit strong negative cooperativity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12935891     DOI: 10.1016/s0014-5793(03)00825-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

Authors:  Matthew L Hemming; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

2.  The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

Authors:  Zenda L Woodman; Sylva L U Schwager; Pierre Redelinghuys; Adriana K Carmona; Mario R W Ehlers; Edward D Sturrock
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 3.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

Review 4.  Interacting cogs in the machinery of the renin angiotensin system.

Authors:  Lizelle Lubbe; Edward D Sturrock
Journal:  Biophys Rev       Date:  2019-06-08

5.  Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.

Authors:  Zhenlong Chen; Fulong Tan; Ervin G Erdös; Peter A Deddish
Journal:  Hypertension       Date:  2005-10-24       Impact factor: 10.190

6.  Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.

Authors:  Olga E Skirgello; Peter V Binevski; Vladimir F Pozdnev; Olga A Kost
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

8.  QM/MM investigation of the catalytic mechanism of angiotensin-converting enzyme.

Authors:  Xia Mu; Chunchun Zhang; Dingguo Xu
Journal:  J Mol Model       Date:  2016-05-16       Impact factor: 1.810

9.  Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

Authors:  Gillian I Rice; Daniel A Thomas; Peter J Grant; Anthony J Turner; Nigel M Hooper
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 10.  Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme.

Authors:  Romer A Gonzalez-Villalobos; Xiao Z Shen; Ellen A Bernstein; Tea Janjulia; Brian Taylor; Jorge F Giani; Wendell-Lamar B Blackwell; Kandarp H Shah; Peng D Shi; Sebastien Fuchs; Kenneth E Bernstein
Journal:  J Mol Med (Berl)       Date:  2013-05-18       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.